Who invested in Novalar Pharmaceuticals?
Novalar Pharmaceuticals's investors include Domain Associates, SR One and Montreux Growth Partners.
United States · Funded startup
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Novalar Pharmaceuticals and see its new rounds in your feed.Start following
Funding summaryUpdated 1 Nov 2026
$31Mraised across 2 rounds since 2007, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $1.0M sold, first sale Jul 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Novalar Pharmaceuticals's investors include Domain Associates, SR One and Montreux Growth Partners.
Novalar Pharmaceuticals has raised $31M across 2 rounds since 2007.
Novalar Pharmaceuticals's most recent round was a Debt of $1.0M in Jul 2010.
Novalar Pharmaceuticals's largest round on record is $30M (Series D), in Nov 2007.
Novalar Pharmaceuticals's first round on record, in Nov 2007, was backed by Domain Associates, SR One and Montreux Growth Partners.
Novalar Pharmaceuticals's latest named round is a Debt, in Jul 2010.
Novalar Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.